AB

Arun Bhati

Active Director Managing Director DIN 08323337
DIN 08323337 First appointment Jan 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2019
Shareholding value Locked Premium profile

About Arun Bhati

Arun Bhati has 7 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Blask Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08323337
Primary Designation Managing Director
First Appointment 08 Jan 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Managing Director08 Jan 20192019Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Blask Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arun Bhati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Bhati

Arun Bhati has 7 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Blask Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Arun Bhati is associated with 1 company as Managing Director.

Arun Bhati has expertise in General Business.

Arun Bhati has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available